- Home
- EQV vs DCTH Comparison
EQV vs DCTH Comparison
Compare EQV & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQV
- DCTH
- Stock Information
- Founded
- EQV 2024
- DCTH 1988
- Country
- EQV United States
- DCTH United States
- Employees
- EQV N/A
- DCTH N/A
- Industry
- EQV
- DCTH Medical/Dental Instruments
- Sector
- EQV
- DCTH Health Care
- Exchange
- EQV Nasdaq
- DCTH Nasdaq
- Market Cap
- EQV 449.7M
- DCTH 518.0M
- IPO Year
- EQV 2024
- DCTH N/A
- Fundamental
- Price
- EQV $10.23
- DCTH $14.84
- Analyst Decision
- EQV
- DCTH Strong Buy
- Analyst Count
- EQV 0
- DCTH 4
- Target Price
- EQV N/A
- DCTH $22.75
- AVG Volume (30 Days)
- EQV 163.7K
- DCTH 408.9K
- Earning Date
- EQV 01-01-0001
- DCTH 05-08-2025
- Dividend Yield
- EQV N/A
- DCTH N/A
- EPS Growth
- EQV N/A
- DCTH N/A
- EPS
- EQV N/A
- DCTH N/A
- Revenue
- EQV N/A
- DCTH $53,850,000.00
- Revenue This Year
- EQV N/A
- DCTH $128.78
- Revenue Next Year
- EQV N/A
- DCTH $54.07
- P/E Ratio
- EQV $49.93
- DCTH N/A
- Revenue Growth
- EQV N/A
- DCTH 1068.87
- 52 Week Low
- EQV $9.88
- DCTH $5.30
- 52 Week High
- EQV $10.25
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- EQV N/A
- DCTH 69.96
- Support Level
- EQV N/A
- DCTH $11.38
- Resistance Level
- EQV N/A
- DCTH $12.49
- Average True Range (ATR)
- EQV 0.00
- DCTH 0.65
- MACD
- EQV 0.00
- DCTH 0.33
- Stochastic Oscillator
- EQV 0.00
- DCTH 75.22
About EQV EQV Ventures Acquisition Corp.
EQV Ventures Acquisition Corp is a blank check company.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.